Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

Clinical trial NCT06953466 · RECRUITING

Trial details

NCT number: NCT06953466
Sponsor: Quoin Pharmaceuticals
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Netherton Syndrome

Start date: 2025-07-01
Primary completion: 2026-07-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.